Clinical Trial Update: Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) [NA]

View source ↗

Summary

A completed clinical trial evaluated stellate ganglion block for COVID-19–related acute respiratory distress syndrome; the status indicates completion, but no e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: West Virginia University | Conditions: Acute Respiratory Distress Syndrome, COVID-19 | NA | Status: COMPLETED